Keeping Current

Hear about the promise of combination therapies and dual and triple agonists in helping people with obesity lose weight and improve overall health.

Credit available for this activity expires: 11/11/26Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003041?ecd=bdc_podcast_libsyn_mscpedu

Untangle the hidden links between chronic inflammation, aging, HIV, and comorbidities.

Credit available for this activity expires: 11/5/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003078?ecd=bdc_podcast_libsyn_mscpedu

How much do you know about new therapies for treating fibrosis in MASH and the patients who can benefit most from them? Credit available for this activity expires: 10/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003068?ecd=bdc_podcast_libsyn_mscpedu

What do expert recommendations say about John Cunningham (JC) virus testing when switching to a biosimilar?

Credit available for this activity expires: 10/31/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/interpreting-jc-virus-test-results-multiple-sclerosis-2025a1000qzm?ecd=bdc_podcast_libsyn_mscpedu

Diabesity at the annual European diabetes meeting: What did you miss?

Credit available for this activity expires: 10/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003003?ecd=bdc_podcast_libsyn_mscpedu

When and how to use longer durability therapies in neovascular age-related macular degeneration (nAMD). Credit available for this activity expires: 10/27/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002961?ecd=bdc_podcast_libsyn_mscpedu

Did you know more patients with prostate cancer die from heart disease than cancer? Learn to master drug interactions to protect both outcomes here.

Credit available for this activity expires: 10/17/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003015?ecd=bdc_podcast_libsyn_mscpedu

The experts discuss strategies, new-generation anti-vascular endothelial growth factors (VEGFs), and the evidence that supports their use.

Credit available for this activity expires: 9/30/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002951?ecd=bdc_podcast_libsyn_mscpedu

Are you aware that programmed cell death-ligand 1 (PD-L1) testing may not be needed to guide immunotherapy decisions in resectable gastric/gastroesophageal junction (GEJ) cancers? Credit available for this activity expires: 9/22/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002919?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on new treatment options for thyroid eye disease?

Credit available for this activity expires: 9/17/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002870?ecd=bdc_podcast_libsyn_mscpedu